LONGITUDINAL FEASIBILITY TESTING OF THE MINDSET VERS 2.1: A CLINIC-BASED DECISION SUPPORT SYSTEM FOR EPILEPSY SELF-MANAGEMENT
Abstract number :
2.229
Submission category :
10. Behavior/Neuropsychology/Language
Year :
2013
Submission ID :
1751321
Source :
www.aesnet.org
Presentation date :
12/7/2013 12:00:00 AM
Published date :
Dec 5, 2013, 06:00 AM
Authors :
C. Begley, R. Shegog, A. Harding, M. Newmark, C. Goldsmith, O. Hope
Rationale: The Management Information & Decision Support Epilepsy Tool ( MINDSET ) is a tablet-based decision support system designed to enhance self-management behaviors of patients with epilepsy though identification of needs, providing tailored behavioral goals, and facilitating communication between the patient and health care provider (HCP) during a regular clinic visit. The purpose of this study is to evaluate the longitudinal functionality of MINDSET for clinical use. Methods: A single group longitudinal study was conducted of adult patients at three participating neurology specialty clinics (n=24). Patients were seen twice in a three month period and interacted with MINDSET prior to each encounter with their HCP. At visit 1 patients entered seizure, medication, and lifestyle management data into MINDSET. An action plan was printed that prioritized goals and strategies tailored to the self-management needs of the patient. This was reviewed and appended by the patient and provider during the visit and taken home by the patient as a decision aid.. At visit 2 patients again entered data into MINDSET. Patients were able to assess their success in meeting self-management goals (based on change in their self-management behaviors since visit 1. Hypotheses relating to feasibility, usability of MINDSET and action plan, perceived impact, shared control of management, correspondence and communication were investigated after each clinic encounter using written survey and interview data collection methods. Results: Preliminary results indicate that patient ratings of time taken to use MINSET were favorable (66%) as were usability ratings of helpfulness (100%), likeability (50-100%), credibility (100%), understandability (50-83%), and motivational appeal (83%). Patients perceived MINDSET as having a positive impact on thinking about and managing their epilepsy (66-83%) and liked the action plan feature (83%). MINDSET was perceived as minimally disruptive to clinic visits by patients and providers with few functional problems reported. Patient ratings for shared decision making were positively skewed, particularly for medical care and medications. Providers were positive about MINDSET indicating they would recommend it to other providers and would continue to use it in their clinic if given the opportunity. The printed action plan has elicited positive responses from both patients and providers. To date, process data has shown that patients reported minimal issues with the content and use of MINDSET.Conclusions: Preliminary findings support previous feasibility data for MINDSET Vers. 1.0. Addition of an action plan component in version 2.1 appears to add utility to the decision-support function for both patients and providers.
Behavior/Neuropsychology